aminosalicylic acid has been researched along with clofazimine in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bera, S; Mondal, D | 1 |
Bhagat, R; Panchal, N; Shah, A | 1 |
Childs, JM; Fish, DN; Malone, RS; Peloquin, CA; Spiegel, DM | 1 |
Chopra, I; Comanducci, A; Oliva, B | 1 |
Adam, RD; Childs, JM; Nix, DE; Peloquin, CA; Zhu, M | 1 |
Cocco, MT; Congiu, C; De Logu, A; Onnis, V; Saddi, B; Schivo, ML | 1 |
Adam, RD; Auclair, B; Godo, PG; Krueger, TS; Nix, DE; Peloquin, CA | 1 |
Agnihotri, SP; Gupta, P; Gupta, S; Jain, NK; Sharma, KK | 1 |
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
Caminero, JA; Migliori, GB; Piubello, A; Scardigli, A | 1 |
Ahmad, N; Baghaei, P; Barkane, L; Benedetti, A; Brode, SK; Brust, JCM; Campbell, JR; Chang, VWL; Falzon, D; Guglielmetti, L; Isaakidis, P; Kempker, RR; Kipiani, M; Kuksa, L; Lan, Z; Lange, C; Laniado-LaborĂn, R; Menzies, D; Nahid, P; Rodrigues, D; Singla, R; Udwadia, ZF | 1 |
Dhamija, RK; Garg, D; Saroha, D; Singh, AK | 1 |
Bodart, L; Buol, X; Derlet, A; Leyssens, T; Tumanov, N; Wouters, J | 1 |
2 review(s) available for aminosalicylic acid and clofazimine
Article | Year |
---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Canada; Clofazimine; Diarylquinolines; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Incidence; Linezolid; Male; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
2 trial(s) available for aminosalicylic acid and clofazimine
Article | Year |
---|---|
Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids.
Topics: Administration, Oral; Adult; Aminosalicylic Acid; Antacids; Antibiotics, Antitubercular; Area Under Curve; Beverages; Citrus; Clofazimine; Cross-Over Studies; Cycloserine; Dietary Fats; Drug Interactions; Electrophoresis, Capillary; Ethionamide; Fasting; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male | 2001 |
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid.
Topics: Administration, Oral; Adult; Aminosalicylic Acid; Antacids; Antitubercular Agents; Beverages; Biological Availability; Citrus sinensis; Clofazimine; Cross-Over Studies; Cycloserine; Dietary Fats; Drug Combinations; Drug Interactions; Ethionamide; Food; Food-Drug Interactions; Humans; Leprostatic Agents; Pyridoxine | 2004 |
11 other study(ies) available for aminosalicylic acid and clofazimine
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas.
Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary | 1993 |
The effect of hemodialysis on cycloserine, ethionamide, para-aminosalicylate, and clofazimine.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Antitubercular Agents; Biological Availability; Clofazimine; Cycloserine; Ethionamide; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 1999 |
Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections.
Topics: Aminosalicylic Acid; Antibiotics, Antitubercular; Bacillus subtilis; Capreomycin; Clofazimine; Dapsone; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Staphylococcus aureus; Viomycin | 1998 |
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Chlorocebus aethiops; Clofazimine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2002 |
Extensively drug resistance (XDR) tb is not always fatal.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Capreomycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Injections; Male; Moxifloxacin; Quinolines; Sputum; Treatment Outcome | 2009 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
Topics: Aminosalicylic Acid; Antitubercular Agents; Carbapenems; Clofazimine; Communicable Disease Control; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Isoniazid; Linezolid; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2017 |
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Cycloserine; Deprescriptions; Diarylquinolines; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Linezolid; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pyrazinamide; Pyridoxine; Tuberculosis, Pulmonary | 2020 |
Combining Two Antitubercular Drugs, Clofazimine and 4-Aminosalicylic Acid, in Order to Improve Clofazimine Aqueous Solubility and 4-Aminosalicylic Acid Thermal Stability.
Topics: Aminosalicylic Acid; Antitubercular Agents; Calorimetry, Differential Scanning; Clofazimine; Solubility; Water; X-Ray Diffraction | 2020 |